-
1دورية أكاديمية
المؤلفون: Lefort, M, Sharmin, S, Andersen, J B, Vukusic, S, Casey, R, Debouverie, M, Edan, G, Ciron, J, Ruet, A, De Sèze, J, Maillart, E, Zephir, H, Labauge, P, Defer, G, Lebrun-Frenay, C, Moreau, T, Berger, E, Clavelou, P, Pelletier, J, Stankoff, B, Gout, O, Thouvenot, E, Heinzlef, O, Al-Khedr, A, Bourre, B, Casez, O, Cabre, P, Montcuquet, A, Wahab, A, Camdessanché, J P, Maurousset, A, Ben Nasr, H, Hankiewicz, K, Pottier, C, Maubeuge, N, Dimitri-Boulos, D, Nifle, C, Laplaud, D A, Horakova, D, Havrdova, E K, Alroughani, R, Izquierdo, G, Eichau, S, Ozakbas, S, Patti, F, Onofrj, M, Lugaresi, A, Terzi, M, Grammond, P, Grand'Maison, F, Yamout, B, Prat, A, Girard, M, Duquette, P, Boz, C, Trojano, M, McCombe, P, Slee, M, Lechner-Scott, J, Turkoglu, R, Sola, P, Ferraro, D, Granella, F, Shaygannejad, V, Prevost, J, Maimone, D, Skibina, O, Buzzard, K, Van der Walt, A, Karabudak, R, Van Wijmeersch, B, Csepany, T, Spitaleri, D, Vucic, S, Koch-Henriksen, N, Sellebjerg, F, Soerensen, P S, Hilt Christensen, C. C., Rasmussen, P V, Jensen, M B, Frederiksen, J L, Bramow, S, Mathiesen, H K, Schreiber, K I, Butzkueven, H, Magyari, M, Kalincik, T, Leray, E
المصدر: Lefort , M , Sharmin , S , Andersen , J B , Vukusic , S , Casey , R , Debouverie , M , Edan , G , Ciron , J , Ruet , A , De Sèze , J , Maillart , E , Zephir , H , Labauge , P , Defer , G , Lebrun-Frenay , C , Moreau , T , Berger , E , Clavelou , P , Pelletier , J , Stankoff , B , Gout , O , Thouvenot , E , Heinzlef , O , Al-Khedr , A , Bourre ....
مصطلحات موضوعية: Fingolimod Hydrochloride/therapeutic use, Humans, Multiple Sclerosis/drug therapy, Multiple Sclerosis, Relapsing-Remitting/drug therapy, Natalizumab/therapeutic use, Treatment Outcome, Effectiveness, Censoring, Propensity score, Causal contrasts, Positivity assumption, Indication bias
وصف الملف: application/pdf
الإتاحة: https://doi.org/10.1186/s12874-022-01623-8Test
https://vbn.aau.dk/da/publications/e1d7ae7e-a89a-4601-8b51-4fdd028bde43Test
https://vbn.aau.dk/ws/files/473179728/Lefort_et_al._2022_._Impact_of_methodological_choices_in_comparative_effectiveness_studies_application_in_natalizumab_versus_fingolimod_comparison_among_patients_with_multiple_sclerosis.pdfTest
http://www.scopus.com/inward/record.url?scp=85130953245&partnerID=8YFLogxKTest -
2دورية أكاديميةFingolimod Therapy in Multiple Sclerosis Leads to the Enrichment of a Subpopulation of Aged NK Cells
المؤلفون: Schwichtenberg, Svenja C., Wisgalla, Anne, Schroeder-Castagno, Maria, Alvarez-González, Cesar, Schlickeiser, Stephan, Siebert, Nadja, Bellmann-Strobl, Judith, Wernecke, Klaus-Dieter, Paul, Friedemann, Dörr, Jan, Infante Duarte, Carmen
المصدر: http://lobid.org/resources/99370674841006441Test#!, 18(3):1783-1797.
مصطلحات موضوعية: Female [MeSH], Cellular Senescence/physiology [MeSH], Multiple sclerosis (MS), Adult [MeSH], Humans [MeSH], Multiple Sclerosis, Relapsing-Remitting/blood [MeSH], Relapsing-Remitting/immunology [MeSH], Prospective Studies [MeSH], Fingolimod Hydrochloride/therapeutic use [MeSH], Longitudinal Studies [MeSH], Middle Aged [MeSH], Sphingosin-1-phosphate receptor (S1PR), Killer Cells, Natural/drug effects [MeSH], Fingolimod Hydrochloride/pharmacology [MeSH], Original Article, Male [MeSH], Relapsing-Remitting/drug therapy [MeSH], Innate lymphoid cells (ILCs), Fingolimod, Cellular Senescence/drug effects [MeSH], Natural/physiology [MeSH], Immunosuppressive Agents/therapeutic use [MeSH], Natural killer (NK) cells, Immunosuppressive Agents/pharmacology [MeSH]
العلاقة: https://repository.publisso.de/resource/frl:6444130Test; https://doi.org/10.1007/s13311-021-01078-7Test; https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8608997Test/
الإتاحة: https://doi.org/10.1007/s13311-021-01078-7Test
https://repository.publisso.de/resource/frl:6444130Test
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8608997Test/ -
3دورية أكاديمية
المؤلفون: Hasan Ali, O., Berner, F., Ackermann, C.J., Ring, S.S., Moulin, A., Müller, J., Markert, E., Pop, O.T., Müller, S., Diem, S., Hundsberger, T., Flatz, L.
المصدر: Cancer immunology, immunotherapy, vol. 70, no. 2, pp. 563-568
مصطلحات موضوعية: Female, Fingolimod Hydrochloride/pharmacology, Fingolimod Hydrochloride/therapeutic use, Humans, Immune Checkpoint Inhibitors/pharmacology, Immune Checkpoint Inhibitors/therapeutic use, Immunosuppressive Agents/pharmacology, Immunosuppressive Agents/therapeutic use, Lymphocytes/immunology, Lymphocytes, Tumor-Infiltrating/immunology, Middle Aged, Neoplasms/drug therapy, Neoplasms/immunology, Cancer, Fingolimod, Immune checkpoint inhibitors, Multiple sclerosis, Oncology, Tumor immunology
وصف الملف: application/pdf
العلاقة: info:eu-repo/semantics/altIdentifier/pmid/32804246; info:eu-repo/semantics/altIdentifier/eissn/1432-0851; info:eu-repo/semantics/altIdentifier/urn/urn:nbn:ch:serval-BIB_57755DC2151E1; https://serval.unil.ch/notice/serval:BIB_57755DC2151ETest; urn:issn:0340-7004; https://serval.unil.ch/resource/serval:BIB_57755DC2151E.P001/REF.pdfTest; http://nbn-resolving.org/urn/resolver.pl?urn=urn:nbn:ch:serval-BIB_57755DC2151E1Test
الإتاحة: https://doi.org/10.1007/s00262-020-02693-7Test
https://serval.unil.ch/notice/serval:BIB_57755DC2151ETest
https://serval.unil.ch/resource/serval:BIB_57755DC2151E.P001/REF.pdfTest
http://nbn-resolving.org/urn/resolver.pl?urn=urn:nbn:ch:serval-BIB_57755DC2151E1Test -
4دورية أكاديمية
المؤلفون: Bourdin, A., Schluep, M., Bugnon, O., Berger, J.
المصدر: American journal of health-system pharmacy, vol. 76, no. 15, pp. 1150-1157
مصطلحات موضوعية: Administration, Oral, Community Networks/organization & administration, Community Pharmacy Services/organization & administration, Delivery of Health Care, Integrated/organization & administration, Female, Fingolimod Hydrochloride/therapeutic use, Humans, Medication Adherence/psychology, Medication Therapy Management/organization & administration, Motivational Interviewing, Multiple Sclerosis, Relapsing-Remitting/drug therapy, Patient Education as Topic, Patient Safety, Patient Transfer/organization & administration, Pharmacists/organization & administration, Pharmacovigilance, Program Development, Switzerland, medication adherence, patient support program, patient-centered care, specialty pharmacy services
وصف الملف: application/pdf
العلاقة: info:eu-repo/semantics/altIdentifier/pmid/31201774; info:eu-repo/semantics/altIdentifier/eissn/1535-2900; info:eu-repo/semantics/altIdentifier/urn/urn:nbn:ch:serval-BIB_D9580C267D8B9; https://serval.unil.ch/notice/serval:BIB_D9580C267D8BTest; urn:issn:1079-2082; https://serval.unil.ch/resource/serval:BIB_D9580C267D8B.P001/REF.pdfTest; http://nbn-resolving.org/urn/resolver.pl?urn=urn:nbn:ch:serval-BIB_D9580C267D8B9Test
الإتاحة: https://doi.org/10.1093/ajhp/zxz106Test
https://serval.unil.ch/notice/serval:BIB_D9580C267D8BTest
https://serval.unil.ch/resource/serval:BIB_D9580C267D8B.P001/REF.pdfTest
http://nbn-resolving.org/urn/resolver.pl?urn=urn:nbn:ch:serval-BIB_D9580C267D8B9Test -
5دورية أكاديمية
المؤلفون: Brown, J. William L., Coles, Alasdair, Horakova, Dana, Havrdova, Eva, Izquierdo, Guillermo, Prat, Alexandre, Girard, Marc, Duquette, Pierre, Trojano, Maria, Lugaresi, Alessandra, Bergamaschi, Roberto, Grammond, Pierre, Alroughani, Raed, Hupperts, Raymond, McCombe, Pamela, Van Pesch, Vincent, Sola, Patrizia, Ferraro, Diana, Grand'Maison, Francois, Terzi, Murat, Lechner-Scott, Jeannette, Flechter, Schlomo, Slee, Mark, Shaygannejad, Vahid, Pucci, Eugenio, Granella, Franco, Jokubaitis, Vilija, Willis, Mark, Rice, Claire, Scolding, Neil, Wilkins, Alastair, Pearson, Owen R., Ziemssen, Tjalf, Hutchinson, Michael, Harding, Katharine, Jones, Joanne, McGuigan, Christopher, Butzkueven, Helmut, Kalincik, Tomas, Robertson, Neil
المصدر: Brown , J W L , Coles , A , Horakova , D , Havrdova , E , Izquierdo , G , Prat , A , Girard , M , Duquette , P , Trojano , M , Lugaresi , A , Bergamaschi , R , Grammond , P , Alroughani , R , Hupperts , R , McCombe , P , Van Pesch , V , Sola , P , Ferraro , D , Grand'Maison , F , Terzi , M , Lechner-Scott , J , Flechter , S , Slee , M , Shaygannejad , V , ....
مصطلحات موضوعية: Adult, Alemtuzumab/therapeutic use, Cohort Studies, Disease Progression, Female, Fingolimod Hydrochloride/therapeutic use, Glatiramer Acetate/therapeutic use, Humans, Immunologic Factors/therapeutic use, Immunosuppressive Agents/therapeutic use, Interferon-beta/therapeutic use, Male, Multiple Sclerosis, Relapsing-Remitting/drug therapy, Natalizumab/therapeutic use, Time-to-Treatment
وصف الملف: application/pdf
العلاقة: https://research-information.bris.ac.uk/en/publications/a55f9cf8-31ba-4e10-a3b8-18c5de6fae5fTest
الإتاحة: https://doi.org/10.1001/jama.2018.20588Test
https://hdl.handle.net/1983/a55f9cf8-31ba-4e10-a3b8-18c5de6fae5fTest
https://research-information.bris.ac.uk/en/publications/a55f9cf8-31ba-4e10-a3b8-18c5de6fae5fTest
https://research-information.bris.ac.uk/ws/files/182040003/DMT_SPMS_conversion_resubmission_3_final_clean.pdfTest
http://www.scopus.com/inward/record.url?scp=85059962064&partnerID=8YFLogxKTest -
6
المؤلفون: Lefort, M, Sharmin, S, Andersen, J B, Vukusic, S, Casey, R, Debouverie, M, Edan, G, Ciron, J, Ruet, A, De Sèze, J, Maillart, E, Zephir, H, Labauge, P, Defer, G, Lebrun-Frenay, C, Moreau, T, Berger, E, Clavelou, P, Pelletier, J, Stankoff, B, Gout, O, Thouvenot, E, Heinzlef, O, Al-Khedr, A, Bourre, B, Casez, O, Cabre, P, Montcuquet, A, Wahab, A, Camdessanché, J P, Maurousset, A, Ben Nasr, H, Hankiewicz, K, Pottier, C, Maubeuge, N, Dimitri-Boulos, D, Nifle, C, Laplaud, D A, Horakova, D, Havrdova, E K, Alroughani, R, Izquierdo, G, Eichau, S, Ozakbas, S, Patti, F, Onofrj, M, Lugaresi, A, Terzi, M, Grammond, P, Grand'Maison, F, Yamout, B, Prat, A, Girard, M, Duquette, P, Boz, C, Trojano, M, McCombe, P, Slee, M, Lechner-Scott, J, Turkoglu, R, Sola, P, Ferraro, D, Granella, F, Shaygannejad, V, Prevost, J, Maimone, D, Skibina, O, Buzzard, K, Van der Walt, A, Karabudak, R, Van Wijmeersch, B, Csepany, T, Spitaleri, D, Vucic, S, Koch-Henriksen, N, Sellebjerg, F, Soerensen, P S, Hilt Christensen, C. C., Rasmussen, P V, Jensen, M B, Frederiksen, J L, Bramow, S, Mathiesen, H K, Schreiber, K I, Butzkueven, H, Magyari, M, Kalincik, T, Leray, E
المساهمون: Centre de Recherches sur l'Action Politique en Europe (ARENES), Université de Rennes (UR)-Institut d'Études Politiques [IEP] - Rennes-École des Hautes Études en Santé Publique [EHESP] (EHESP)-Centre National de la Recherche Scientifique (CNRS), Recherche sur les services et le management en santé (RSMS), Université de Rennes (UR)-École des Hautes Études en Santé Publique [EHESP] (EHESP)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), Centre d'Investigation Clinique [Rennes] (CIC), Université de Rennes (UR)-Hôpital Pontchaillou-Institut National de la Santé et de la Recherche Médicale (INSERM), CHU Pontchaillou [Rennes], University of Melbourne, Copenhagen University Hospital, Hospices Civils de Lyon (HCL), Centre de recherche en neurosciences de Lyon - Lyon Neuroscience Research Center (CRNL), Université Claude Bernard Lyon 1 (UCBL), Université de Lyon-Université de Lyon-Université Jean Monnet - Saint-Étienne (UJM)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), Fondation Eugène Devic EDMUS, Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy), Centre Hospitalier Universitaire de Toulouse (CHU Toulouse), i-SEP (i-SEP), CIC Strasbourg (Centre d’Investigation Clinique Plurithématique (CIC - P) ), Université de Strasbourg (UNISTRA)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Nouvel Hôpital Civil de Strasbourg-Hôpital de Hautepierre [Strasbourg], CHU Pitié-Salpêtrière [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU), CHU Lille, Centre Hospitalier Régional Universitaire [Montpellier] (CHRU Montpellier), Université de Montpellier (UM), Service de Neurologie [CHU Caen], Université de Caen Normandie (UNICAEN), Normandie Université (NU)-Normandie Université (NU)-CHU Caen, Normandie Université (NU)-Tumorothèque de Caen Basse-Normandie (TCBN)-Tumorothèque de Caen Basse-Normandie (TCBN), Centre Hospitalier Universitaire de Nice (CHU Nice), Centre Hospitalier Universitaire de Dijon - Hôpital François Mitterrand (CHU Dijon), Centre Hospitalier Régional Universitaire de Besançon (CHRU Besançon), Service de Neurologie [CHU Clermont-Ferrand], CHU Gabriel Montpied [Clermont-Ferrand], CHU Clermont-Ferrand-CHU Clermont-Ferrand-CHU Estaing [Clermont-Ferrand], CHU Clermont-Ferrand, Hôpital de la Timone [CHU - APHM] (TIMONE), CHU Saint-Antoine [AP-HP], Fondation Ophtalmologique Adolphe de Rothschild [Paris], Service de Neurologie [CHU Nimes] (Pôle NIRR), Hôpital Universitaire Carémeau [Nîmes] (CHU Nîmes), Centre Hospitalier Universitaire de Nîmes (CHU Nîmes)-Centre Hospitalier Universitaire de Nîmes (CHU Nîmes), Institut de Génomique Fonctionnelle (IGF), Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)-Université de Montpellier (UM), CHI Poissy-Saint-Germain, CHU Amiens-Picardie, CHU Rouen, Normandie Université (NU), Centre Hospitalier Universitaire [Grenoble] (CHU), Centre hospitalier universitaire de Nantes (CHU Nantes), Centre de Recherche en Transplantation et Immunologie - Center for Research in Transplantation and Translational Immunology (U1064 Inserm - CR2TI), Institut National de la Santé et de la Recherche Médicale (INSERM)-Nantes Université - UFR de Médecine et des Techniques Médicales (Nantes Univ - UFR MEDECINE), Nantes Université - pôle Santé, Nantes Université (Nantes Univ)-Nantes Université (Nantes Univ)-Nantes Université - pôle Santé, Nantes Université (Nantes Univ)-Nantes Université (Nantes Univ), Monash University [Melbourne], The Royal Melbourne Hospital, École des Hautes Études en Santé Publique [EHESP] (EHESP), Université de Rennes (UR), Département Méthodes quantitatives en santé publique (METIS), Collectif de recherche handicap, autonomie et société inclusive (CoRHASI), OFSEP was supported by a grant provided by the French State and handled by the 'Agence Nationale de la Recherche', within the framework of the 'Investments for the Future' program, under the reference ANR-10-COHO-002, by the Eugène Devic EDMUS Foundation against multiple sclerosis and by the ARSEP Foundation. ML has recieved travel grant from ARSEP foundation for this project. The Clinical Outcomes Research unit at the University of Melbourne received funding from NHMRC (grant number 1140766, 1129789, and 1157717) to support this study. The MSBase Foundation is a not-for-profit organization that receives support from Biogen, Novartis, Merck, Roche, Teva Pharmaeutical Industries and Sanofi Genzyme. The Danish Multiple Sclerosis Registry did not receive any funding to collaborate in this study., ANR-10-COHO-0002,OFSEP,Observatoire Français de la Sclérose en Plaques(2010), Université de Rennes 1 (UR1), Université de Rennes (UNIV-RENNES)-Université de Rennes (UNIV-RENNES)-Institut d'Études Politiques [IEP] - Rennes-École des Hautes Études en Santé Publique [EHESP] (EHESP)-Centre National de la Recherche Scientifique (CNRS), Université de Rennes (UNIV-RENNES)-Université de Rennes (UNIV-RENNES)-École des Hautes Études en Santé Publique [EHESP] (EHESP)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), Université de Rennes (UNIV-RENNES)-Université de Rennes (UNIV-RENNES)-Hôpital Pontchaillou-Institut National de la Santé et de la Recherche Médicale (INSERM), Université de Lyon-Université de Lyon-Université Jean Monnet [Saint-Étienne] (UJM)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), CHU Toulouse [Toulouse], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Centre Hospitalier Universitaire de Nîmes (CHU Nîmes), Université de Rennes (UNIV-RENNES), Bramow, Stephan/0000-0001-9482-1771, Sellebjerg, Finn/0000-0002-1333-9623, Heinzlef, O., Camdessanche, J. P., Turkoglu, R., Boz, C., Shaygannejad, V, Moreau, T., Sellebjerg, F., Onofrj, M., De Seze, J., Wahab, A., VAN WIJMEERSCH, Bart, Mathiesen, H. K., Bramow, S., Andersen, J. B., Zephir, H., Ben Nasr, H., Ciron, J., Al-Khedr, A., Granella, F., Spitaleri, D., Lebrun-Frenay, C., Ferraro, D., Trojano, M., Labauge, P., Thouvenot, E., Skibina, O., Magyari, M., Patti, F., Maimone, D., Kalincik, T., Buzzard, K., Dimitri-Boulos, D., Alroughani, R., Maillart, E., Koch-Henriksen, N., Hankiewicz, K., Rasmussen, P., V, Jensen, M. B., Lechner-Scott, J., Csepany, T., Casez, O., Soerensen , P. S., Lugaresi, A., McCombe, P., Defer, G., Terzi, M., Christensen, C. C. Hilt, Girard, M., Ruet, A., Berger , E., Maurousset, A., Duquette, P., Horakova, D., Laplaud, D. A., Casey, R., Edan, G., Schreiber, K., I, Lefort, M., Cabre, P., Maubeuge, N., Grammond, P., Prevost, J., Havrdova, E. K., Gout, O., Prat, A., Sola, P., Slee, M., Sharmin , S., Leray, E., Ozakbas, S., Grand'Maison, F., Montcuquet, A., Nifle, C., Eichau, S., Butzkueven, H., Karabudak, R., Vukusic, S., Debouverie, M., Clavelou, P., Stankoff, B., Pottier, C., Yamout, B., Vucic, S., Van der Walt, A., Pelletier, J., Bourre, B., Izquierdo, G., Frederiksen, J. L., Lefort, M, Sharmin, S, Andersen, J B, Vukusic, S, Casey, R, Debouverie, M, Edan, G, Ciron, J, Ruet, A, De Sèze, J, Maillart, E, Zephir, H, Labauge, P, Defer, G, Lebrun-Frenay, C, Moreau, T, Berger, E, Clavelou, P, Pelletier, J, Stankoff, B, Gout, O, Thouvenot, E, Heinzlef, O, Al-Khedr, A, Bourre, B, Casez, O, Cabre, P, Montcuquet, A, Wahab, A, Camdessanché, J P, Maurousset, A, Ben Nasr, H, Hankiewicz, K, Pottier, C, Maubeuge, N, Dimitri-Boulos, D, Nifle, C, Laplaud, D A, Horakova, D, Havrdova, E K, Alroughani, R, Izquierdo, G, Eichau, S, Ozakbas, S, Patti, F, Onofrj, M, Lugaresi, A, Terzi, M, Grammond, P, Grand'Maison, F, Yamout, B, Prat, A, Girard, M, Duquette, P, Boz, C, Trojano, M, McCombe, P, Slee, M, Lechner-Scott, J, Turkoglu, R, Sola, P, Ferraro, D, Granella, F, Prevost, J, Maimone, D, Skibina, O, Buzzard, K, Van der Walt, A, Karabudak, R, Van Wijmeersch, B, Csepany, T, Spitaleri, D, Vucic, S, Koch-Henriksen, N, Sellebjerg, F, Soerensen, P S, Hilt Christensen, C C, Rasmussen, P V, Jensen, M B, Frederiksen, J L, Bramow, S, Mathiesen, H K, Schreiber, K I, Butzkueven, H, Magyari, M, Kalincik, T, Leray, E
المصدر: Lefort, M, Sharmin, S, Andersen, J B, Vukusic, S, Casey, R, Debouverie, M, Edan, G, Ciron, J, Ruet, A, De Sèze, J, Maillart, E, Zephir, H, Labauge, P, Defer, G, Lebrun-Frenay, C, Moreau, T, Berger, E, Clavelou, P, Pelletier, J, Stankoff, B, Gout, O, Thouvenot, E, Heinzlef, O, Al-Khedr, A, Bourre, B, Casez, O, Cabre, P, Montcuquet, A, Wahab, A, Camdessanché, J P, Maurousset, A, Ben Nasr, H, Hankiewicz, K, Pottier, C, Maubeuge, N, Dimitri-Boulos, D, Nifle, C, Laplaud, D A, Horakova, D, Havrdova, E K, Alroughani, R, Izquierdo, G, Eichau, S, Ozakbas, S, Patti, F, Onofrj, M, Lugaresi, A, Terzi, M, Grammond, P, Grand’Maison, F, Yamout, B, Prat, A, Girard, M, Duquette, P, Boz, C, Trojano, M, McCombe, P, Slee, M, Lechner-Scott, J, Turkoglu, R, Sola, P, Ferraro, D, Granella, F, Shaygannejad, V, Prevost, J, Maimone, D, Skibina, O, Buzzard, K, Van der Walt, A, Karabudak, R, Van Wijmeersch, B, Csepany, T, Spitaleri, D, Vucic, S, Koch-Henriksen, N, Sellebjerg, F, Soerensen, P S, Hilt Christensen, C C, Rasmussen, P V, Jensen, M B, Frederiksen, J L, Bramow, S, Mathiesen, H K, Schreiber, K I, Butzkueven, H, Magyari, M, Kalincik, T & Leray, E 2022, ' Impact of methodological choices in comparative effectiveness studies : application in natalizumab versus fingolimod comparison among patients with multiple sclerosis ', BMC Medical Research Methodology, vol. 22, no. 1, 155 . https://doi.org/10.1186/s12874-022-01623-8Test
BMC Medical Research Methodology
BMC Medical Research Methodology, 2022, 22 (1), pp.155. ⟨10.1186/s12874-022-01623-8⟩
BMC Medical Research Methodology, BioMed Central, 2022, 22 (1), pp.155. ⟨10.1186/s12874-022-01623-8⟩
Lefort, M, Sharmin, S, Andersen, J B, Vukusic, S, Casey, R, Debouverie, M, Edan, G, Ciron, J, Ruet, A, De Sèze, J, Maillart, E, Zephir, H, Labauge, P, Defer, G, Lebrun-Frenay, C, Moreau, T, Berger, E, Clavelou, P, Pelletier, J, Stankoff, B, Gout, O, Thouvenot, E, Heinzlef, O, Al-Khedr, A, Bourre, B, Casez, O, Cabre, P, Montcuquet, A, Wahab, A, Camdessanché, J P, Maurousset, A, Ben Nasr, H, Hankiewicz, K, Pottier, C, Maubeuge, N, Dimitri-Boulos, D, Nifle, C, Laplaud, D A, Horakova, D, Havrdova, E K, Alroughani, R, Izquierdo, G, Eichau, S, Ozakbas, S, Patti, F, Onofrj, M, Lugaresi, A, Terzi, M, Grammond, P, Grand'Maison, F, Yamout, B, Prat, A, Girard, M, Duquette, P, Boz, C, Trojano, M, McCombe, P, Slee, M, Lechner-Scott, J, Turkoglu, R, Sola, P, Ferraro, D, Granella, F, Shaygannejad, V, Prevost, J, Maimone, D, Skibina, O, Buzzard, K, Van der Walt, A, Karabudak, R, Van Wijmeersch, B, Csepany, T, Spitaleri, D, Vucic, S, Koch-Henriksen, N, Sellebjerg, F, Soerensen, P S, Hilt Christensen, C C, Rasmussen, P V, Jensen, M B, Frederiksen, J L, Bramow, S, Mathiesen, H K, Schreiber, K I, Butzkueven, H, Magyari, M, Kalincik, T & Leray, E 2022, ' Impact of methodological choices in comparative effectiveness studies : application in natalizumab versus fingolimod comparison among patients with multiple sclerosis ', BMC Medical Research Methodology, vol. 22, no. 1, 155 . https://doi.org/10.1186/s12874-022-01623-8Testمصطلحات موضوعية: MESH: Fingolimod Hydrochloride, Indication bias, Multiple Sclerosis, MESH: Multiple Sclerosis, Relapsing-Remitting, Propensity score, Epidemiology, Positivity assumption, [SDV]Life Sciences [q-bio], Health Informatics, Effectiveness, Multiple sclerosis, Multiple Sclerosis, Relapsing-Remitting, Multiple Sclerosi, Humans, Fingolimod Hydrochloride/therapeutic use, MESH: Treatment Outcome, Censoring, Natalizumab/therapeutic use, MESH: Humans, Fingolimod Hydrochloride, Natalizumab, Effectivene, Causal contrasts, MESH: Natalizumab, MESH: Multiple Sclerosis, Multiple Sclerosis, Relapsing-Remitting/drug therapy, Causal contrast, Treatment Outcome, Multiple Sclerosis/drug therapy, Indication bia, Human
وصف الملف: application/pdf; ELETTRONICO
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b76c9aa3b89340f07462e048e392906eTest
https://avesis.deu.edu.tr/publication/details/fef052b9-7e13-4a9f-b86e-a900c3dd0924/oaiTest -
7دورية أكاديمية
المؤلفون: Sieber, C., Chiavi, D., Haag, C., Kaufmann, M., Horn, A.B., Dressel, H., Zecca, C., Calabrese, P., Pot, C., Kamm, C.P., von Wyl, V.
المساهمون: Swiss Multiple Sclerosis Registry, Anderseck, B., Chan, A., Gobbi, C., Häussler, R., Kesselring, J., Kuhle, J., Kurmann, R., Lotter, C., Luyckx, K., Monin, P., Müller, S., Nedeltchev, K., A Puhan, M., Rapold, I., Salmen, A., Enno Stephan, K., Manjaly, Z.M., Vaney, C.
المصدر: JMIR mHealth and uHealth, vol. 10, no. 10, pp. e38709
مصطلحات موضوعية: Adult, Crotonates, Electronics, Female, Fingolimod Hydrochloride/therapeutic use, Glatiramer Acetate/therapeutic use, Humans, Hydroxybutyrates, Interferon beta-1a/therapeutic use, Male, Medical Records, Middle Aged, Multiple Sclerosis, Nitriles, Quality of Life, Toluidines, adherence, diary, digital health, electronic health diary, natural language processing, participation, patient-reported outcome, registry, unstructured text
العلاقة: info:eu-repo/semantics/altIdentifier/pmid/36197713; info:eu-repo/semantics/altIdentifier/eissn/2291-5222; https://serval.unil.ch/notice/serval:BIB_F4E200A2CF4BTest; urn:issn:2291-5222
-
8دورية أكاديمية
المؤلفون: Disanto, G., Benkert, P., Lorscheider, J., Mueller, S., Vehoff, J., Zecca, C., Ramseier, S., Achtnichts, L., Findling, O., Nedeltchev, K., Radue, E.W., Sprenger, T., Stippich, C., Derfuss, T., Louvion, J.F., Kamm, C.P., Mattle, H.P., Lotter, C., Du Pasquier, R., Schluep, M., Pot, C., Lalive, P.H., Yaldizli, Ö., Gobbi, C., Kappos, L., Kuhle, J., SMSC Scientific, Board
المساهمون: SMSC Scientific, Board, Ramseier, S., Achtnichts, L., Findling, O., Saxer, J., Nedeltchev, K., Remonda, L., Boxheimer, L., Kuhle, J., Kappos, L., Yaldizli£££Özguer£££ Ö., Derfuss, T., Sprenger, T., Limberg, M., Scheerer, I., Orleth, A., Treppke, F., Beregi, E., Stippich, C., Reinhardt, J., Fellner, I., Würfel, J., Radue, EW., Thoeni, A., Palatini, A., Pauli-Magnus, C., Fabbro, T., Benkert, P., Roesler, A., Mechati, S., Louvion, JF., Kamm, C., Chan, A., Mattle, H., Salmen, A., Kaeser, M., Wagner, F., Verma, R., Lalive, P., Di Marco, M., Haller, S., Lovblad, KO., Du Pasquier, R., Schluep, M., Pot, C., Granziera, C., Hagmann, P., Maeder, P., Gobbi, C., Zecca, C., Disanto, G., Tschuor, S., Cianfoni, A., Müller, S., Vehoff, J., Weber, J., Lotter, C.
المصدر: Plos One, vol. 11, no. 3, pp. e0152347
مصطلحات موضوعية: Adult, Biomarkers/blood, Biomarkers/cerebrospinal fluid, Brain/radiography, Cohort Studies, Demography, Female, Fingolimod Hydrochloride/therapeutic use, Follow-Up Studies, Humans, Immunosuppressive Agents/therapeutic use, Magnetic Resonance Imaging, Male, Middle Aged, Multiple Sclerosis/diagnosis, Multiple Sclerosis/drug therapy, Natalizumab/therapeutic use, Prognosis, Prospective Studies, Recurrence, Switzerland
وصف الملف: application/pdf
العلاقة: info:eu-repo/semantics/altIdentifier/pmid/27032105; info:eu-repo/semantics/altIdentifier/eissn/1932-6203; info:eu-repo/semantics/altIdentifier/urn/urn:nbn:ch:serval-BIB_745A35B87D485; https://serval.unil.ch/notice/serval:BIB_745A35B87D48Test; urn:issn:1932-6203; https://serval.unil.ch/resource/serval:BIB_745A35B87D48.P001/REF.pdfTest; http://nbn-resolving.org/urn/resolver.pl?urn=urn:nbn:ch:serval-BIB_745A35B87D485Test
الإتاحة: https://doi.org/10.1371/journal.pone.0152347Test
https://serval.unil.ch/notice/serval:BIB_745A35B87D48Test
https://serval.unil.ch/resource/serval:BIB_745A35B87D48.P001/REF.pdfTest
http://nbn-resolving.org/urn/resolver.pl?urn=urn:nbn:ch:serval-BIB_745A35B87D485Test -
9دورية أكاديمية
المؤلفون: Serdar, Meray, Herz, Josephine, Kempe, Karina, Lumpe, Katharina, Reinboth, Barbara S, Sizonenko, Stéphane, Hou, Xinlin, Herrmann, Ralf, Hadamitzky, Martin, Heumann, Rolf, Hansen, Wiebke, Sifringer, Marco, Van De Looij, Yohan, Felderhoff-Müser, Ursula, Bendix, Ivo
المصدر: ISSN: 1090-2139 ; Brain, behavior, and immunity, vol. 52 (2016) p. 106-119.
مصطلحات موضوعية: info:eu-repo/classification/ddc/618, Animals, Newborn, Brain/metabolism, Cognition Disorders/metabolism/pathology/prevention & control, Diffusion Magnetic Resonance Imaging, Female, Fingolimod Hydrochloride/therapeutic use, Hyperoxia/drug therapy/pathology, Lysophospholipids/metabolism, Male, Microglia/drug effects/metabolism/pathology, Nerve Fibers, Myelinated/drug effects, Oligodendroglia/drug effects/metabolism/pathology, Oxygen/administration & dosage, Pregnancy, Random Allocation, Rats, Wistar, Receptors, Lysosphingolipid/antagonists & inhibitors/metabolism, Sphingosine/analogs & derivatives/metabolism, White Matter/drug effects/metabolism/pathology
العلاقة: info:eu-repo/semantics/altIdentifier/pmid/26456693; https://archive-ouverte.unige.ch/unige:96680Test; unige:96680
-
10
المؤلفون: Stefan Diem, Oltin T Pop, Joachim Müller, Alexandre Moulin, Sandra S. Ring, Omar Ali, Stefanie Müller, Lukas Flatz, Christoph Jakob Ackermann, Thomas Hundsberger, Fiamma Berner, Eva Markert
المساهمون: University of Zurich, Flatz, Lukas
المصدر: Cancer immunology, immunotherapy, vol. 70, no. 2, pp. 563-568
Cancer Immunology, Immunotherapyمصطلحات موضوعية: Research Report, Cancer Research, Lymphocyte, Immunology, 610 Medicine & health, chemical and pharmacologic phenomena, Pembrolizumab, Multiple sclerosis, Immune checkpoint inhibitors, 03 medical and health sciences, Lymphocytes, Tumor-Infiltrating, 0302 clinical medicine, Immune system, Female, Fingolimod Hydrochloride/pharmacology, Fingolimod Hydrochloride/therapeutic use, Humans, Immune Checkpoint Inhibitors/pharmacology, Immune Checkpoint Inhibitors/therapeutic use, Immunosuppressive Agents/pharmacology, Immunosuppressive Agents/therapeutic use, Lymphocytes/immunology, Lymphocytes, Tumor-Infiltrating/immunology, Middle Aged, Neoplasms/drug therapy, Neoplasms/immunology, Cancer, Fingolimod, Oncology, Tumor immunology, Neoplasms, medicine, Immunology and Allergy, 1306 Cancer Research, Lymphocytes, 2403 Immunology, Fingolimod Hydrochloride, Tumor-infiltrating lymphocytes, business.industry, Melanoma, 10177 Dermatology Clinic, medicine.disease, 3. Good health, medicine.anatomical_structure, 030220 oncology & carcinogenesis, 2723 Immunology and Allergy, Cancer research, 2730 Oncology, business, Immunosuppressive Agents, 030217 neurology & neurosurgery, medicine.drug
وصف الملف: application/pdf; Hasan_Ali_CII.pdf - application/pdf
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::50dff028bc2af180e99598e3d2894abbTest
https://serval.unil.ch/notice/serval:BIB_57755DC2151ETest